Detalles de la búsqueda
1.
Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability.
Acta Pharmacol Sin
; 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38902501
2.
Role of NADPH Oxidase-Induced Hypoxia-Induced Factor-1α Increase in Blood-Brain Barrier Disruption after 2-Hour Focal Ischemic Stroke in Rat.
Neural Plast
; 2021: 9928232, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34434231
3.
Dl-NBP (Dl-3-N-Butylphthalide) Treatment Promotes Neurological Functional Recovery Accompanied by the Upregulation of White Matter Integrity and HIF-1α/VEGF/Notch/Dll4 Expression.
Front Pharmacol
; 10: 1595, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32038259
4.
Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia.
Front Cell Neurosci
; 12: 288, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30233326
5.
The degradation of mixed lineage kinase domain-like protein promotes neuroprotection after ischemic brain injury.
Oncotarget
; 8(40): 68393-68401, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978125
6.
Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.
Neurotox Res
; 28(1): 1-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25697425
7.
Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice.
Sci Rep
; 5: 16751, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26572587
Resultados
1 -
7
de 7
1
Próxima >
>>